Agronomics (ANIC) AI Stock Analysis

• Market Cap: £87.82M
• Dividend Yield: N/A
• Average Volume (3M): 2.73M
• Price to Earnings (P/E): ―
• Beta (1Y): 1.14
• Revenue Growth: N/A
• EPS Growth: -600.00%
• Country: UK
• Employees: N/A
• Sector: Financial
• Sector Strength: 78
• Industry: Asset Management
• EPS (TTM): -0.02
• Shares Outstanding: 1,009,417,300
• 10 Day Avg. Volume: 4,634,010
• 30 Day Avg. Volume: 2,726,556
• PEG Ratio: -0.20
• Price to Book (P/B): 1.04
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -9.28
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: £15.90
• Price Target Upside: 76.27% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 0

• Rating: 48 Neutral
• Price Target: ―

Agronomics Limited faces significant financial challenges, with erratic income and negative cash flows weighing heavily on its score. However, a strong balance sheet and promising corporate events, such as strategic partnerships and innovations in sustainable food, provide some hope. Weak technical signals and poor valuation further suppress the overall score, indicating an uphill battle for stronger investment appeal.

Agronomics Business Overview & Revenue Model

Company Description

Agronomics Limited is a principal investment firm specializing in investments in funds, equity and equity related products. The firm invests in quoted and unquoted companies. It prefers to invest in the alternative proteins company with a focus on cellular agriculture, nascent industry of modern foods, biopharma sector and will establish a portfolio of investments in biotechnology and biopharmaceutical companies. The firm may also invest in shares of collective investment schemes with exposure to the biopharma sector and in long-term equity anticipation securities the underlying securities of which will be based on biopharma sector securities and/or indices relating to the biopharma Sector. It may invest in biopharma sector debt, where investments shall not exceed 15 per cent of the net asset value of the company. Agronomics Limited was founded on May 3, 2011 and is based in Ramsey, Isle of Man.

How the Company Makes Money

Agronomics Limited makes money through strategic investments in early-stage companies within the cellular agriculture sector. The company's revenue model is primarily based on capital appreciation and returns from equity stakes in these companies. Agronomics often invests in businesses that are pioneering novel food production methods, such as lab-grown meat and alternative proteins, which have the potential to disrupt traditional food industries. The company may also derive income from dividends or interest payments from its investment portfolio. Significant partnerships with leading players in the food technology space and a focus on high-growth potential ventures contribute to its earnings.

Agronomics Financial Statement Overview

Summary

Agronomics Limited faces significant revenue and profit volatility impacting its income statement, scoring 32.0. The balance sheet is strong with zero debt, scoring 78.0, but cash flows are negative, scoring 40.0. Overall, the financial landscape is challenging due to poor income but stable due to a solid balance sheet.

Income Statement

Agronomics Limited shows significant volatility in revenue, with drastic declines in the TTM and recent annual periods. Gross and net margins have turned negative, indicating profitability challenges. The company needs to improve revenue consistency and cost management to achieve sustainable growth.

Balance Sheet

The company maintains a strong balance sheet with zero debt, resulting in a favorable debt-to-equity ratio. High stockholders' equity and cash reserves provide a cushion for financial stability. However, a decreasing equity ratio indicates a need to optimize asset utilization.

Cash Flow

Cash flows remain under pressure, with negative operating cash flow and free cash flow in the latest periods. Dependence on financing activities to cover cash shortfalls suggests a need for better operational cash management to support business activities sustainably.

Breakdown	TTM	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Income Statement
Total Revenue	-14.68M	-8.34M	29.70M	440.32K	260.10K	1.28M
Gross Profit	-14.68M	-8.34M	29.70M	440.32K	10.67M	1.28M
EBITDA	0.00	0.00	0.00	1.50M	-9.43M	930.00
Net Income	-17.11M	-10.99M	22.37M	8.36M	1.02M	611.73K
Balance Sheet
Total Assets	150.88M	157.44M	170.20M	146.40M	101.65M	19.55M
Cash, Cash Equivalents and Short-Term Investments	150.78M	12.24M	169.87M	146.30M	101.21M	19.53M
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00
Total Liabilities	161.39K	166.17K	1.95M	2.49M	1.62M	131.08K
Stockholders Equity	150.72M	157.27M	168.26M	143.91M	100.03M	19.42M
Cash Flow
Free Cash Flow	-11.58M	-15.86M	-23.67M	-42.21M	-12.17M	-666.38K
Operating Cash Flow	-11.58M	-15.86M	-24.40M	-42.21M	-12.17M	-666.38K
Investing Cash Flow	6.36M	892.00K	10.02M	-20.02M	-11.21M	-14.15M
Financing Cash Flow	-229.03K	1.68K	1.01M	31.25M	71.82M	17.19M

Agronomics Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 9.02
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:ANIC, the sentiment is Positive. The current price of 9.02 is above the 20-day moving average (MA) of 7.39, above the 50-day MA of 6.92, and above the 200-day MA of 5.46, indicating a bullish trend. The MACD of 0.40 indicates Negative momentum. The RSI at 78.35 is Negative, neither overbought nor oversold. The STOCH value of 89.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:ANIC.

Agronomics Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	61 Neutral	C$14.65B	6.10	22.26%	5.60%	27.38%	-22.40%
FIPP	54 Neutral	£14.12M	―	-8.99%	―	-20.43%	-104.66%
ANIC	48 Neutral	£87.82M	―	-10.74%	―	―	-600.00%
MVIR		£61.25M	7.05	17.28%	―	―	―
KROEF		$79.20M	7.21	4.66%	―	―	―
450		£14.09M	―	-13.15%	―	―	―
DORE	62 Neutral	£148.01M	35.00		5.75%	―	―

Agronomics Corporate Events

Agronomics’ BlueNalu Expands Partnership with Nomad Foods for UK and Europe Market Entry

Agronomics Limited announced that its portfolio company, BlueNalu, has expanded its partnership with Nomad Foods to commercialize cell-cultivated seafood in the UK and Europe. This partnership will focus on market-entry strategies for BlueNalu’s seafood products, starting with premium foodservice offerings. BlueNalu’s involvement in the UK Food Standards Agency’s regulatory program is expected to expedite the approval process for cultivated foods, reinforcing its position as a leader in food system innovation. Recent research indicates strong consumer interest in BlueNalu’s cell-cultivated bluefin tuna toro, highlighting the product’s potential health and environmental benefits.

Spark’s Take on GB:ANIC Stock

According to Spark, TipRanks’ AI Analyst, GB:ANIC is a Neutral.

Agronomics Limited’s overall stock score reflects a mix of strong strategic initiatives and financial challenges. The company benefits from innovative projects and a strong balance sheet, but significant revenue volatility and valuation concerns weigh down the score. Strategic improvements are needed for stronger investment appeal.

To see Spark’s full report on GB:ANIC stock, click here.

Agronomics’ Liberation Labs Partners with NEOM for Saudi Fermentation Facility

Agronomics Limited announced that its portfolio company, Liberation Labs, has formed a strategic partnership with NEOM Investment Fund to develop a precision-fermentation facility in Saudi Arabia. This collaboration aims to bolster Saudi Arabia’s food security and establish NEOM as a leader in sustainable food production, with Liberation Labs leveraging its expertise in precision fermentation to produce high-value proteins without animals. The partnership is expected to create economic opportunities and high-skilled jobs, positioning Liberation Labs at the forefront of the industrial biotechnology sector.

Spark’s Take on GB:ANIC Stock

According to Spark, TipRanks’ AI Analyst, GB:ANIC is a Neutral.

Agronomics Limited’s overall stock score reflects a mix of strong strategic initiatives and financial challenges. The company’s innovative projects and strong balance sheet provide a positive outlook, but significant revenue volatility and valuation concerns weigh down the score. Strategic improvements are needed for stronger investment appeal.

To see Spark’s full report on GB:ANIC stock, click here.

Agronomics Limited Announces Share Option Exercise by Shellbay

Agronomics Limited announced that Shellbay Investments Limited, indirectly owned by Executive Chair Jim Mellon, has exercised options over 2,289,549 shares, transferring them to an advisory consultant. This transaction leaves Shellbay with 24,097 shares, while the company’s total issued share capital remains unchanged. This move reflects ongoing strategic maneuvers within the company, potentially impacting its market positioning and stakeholder interests.

Agronomics Limited Reports Interim Results Amidst Portfolio Progress

Agronomics Limited reported a decrease in its Net Asset Value per share by 4.1% for the six-month period ending December 2024, with a net loss of £6.55 million. Despite financial setbacks, the company showcased significant technological and commercial progress within its portfolio, raising close to US$400 million collectively. Notable achievements include successful funding rounds for portfolio companies like Formo and Meatly, and regulatory approvals for All G, indicating a strong positioning in the cultivated food sector. The company anticipates 2025 to be transformative, with expectations of regulatory approvals and commercialization of products, alongside infrastructure developments like Liberation Labs’ biomanufacturing facility.

Agronomics’ Solar Foods Secures €10 Million Grant for Expansion

Agronomics Limited announced that its portfolio company, Solar Foods, has secured a €10 million grant from Business Finland to support the commissioning of a new commercial-scale production facility, Factory 02. This funding is part of Solar Foods’ growth strategy to expand its production capabilities and commercialize its Solein® protein, which is produced using carbon dioxide and electricity, offering a sustainable alternative to traditional agriculture. The new facility is expected to significantly increase production capacity and reduce costs, further positioning Solar Foods as a leader in the clean food industry.

Agronomics’ Meatly Unveils World’s First Cultivated Meat Dog Treat

Agronomics Limited announced that its portfolio company, Meatly, has launched the world’s first cultivated meat dog treat, now on sale at Pets at Home in London. This innovative product, ‘Chick Bites,’ combines plant-based ingredients with cultivated chicken meat, offering a sustainable alternative to traditional pet food. Meatly plans to expand its production and aims to make its products more widely available within the next 3-5 years. This launch marks a significant step in the pet food market, aligning with the industry’s growing demand for sustainable practices, as pets consume a substantial portion of meat, contributing to environmental impacts. Agronomics, having invested £1.2 million in Meatly, holds a 25.54% equity stake, highlighting its commitment to supporting sustainable innovations in food production.